The Need to Enrich Population Diversity in Radiogenomic Research

Affiliations

¹ Departments of Radiation Oncology and Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: barry.rosenstein@mssm.edu.
² Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.
³ Division of Biostatistics and Bioinformatics, Department of Epidemiology and Public Health, University of Maryland Greenebaum Comprehensive Cancer Center and University of Maryland School of Medicine, Baltimore, Maryland.
⁴ Department of Radiation Oncology, The Medical College of Wisconsin, Milwaukee, Wisconsin.
⁵ Biosciences Division, SRI International, Menlo Park, California.
⁶ Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom.
⁷ Fundación Pública Galega Medicina Xenómica, Instituto de Investigacion Sanitaria de Santiago de Compostela, Hospital Clínico Santiago de Compostela, Santiago de Compostela, A Coruña, Spain.
⁸ Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
⁹ Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida.

Editorial

Barry S Rosenstein et al. Int J Radiat Oncol Biol Phys. 2024.

. 2024 Nov 15;120(4):1107-1110.

doi: 10.1016/j.ijrobp.2024.06.012.

¹ Departments of Radiation Oncology and Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: barry.rosenstein@mssm.edu.
² Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.
³ Division of Biostatistics and Bioinformatics, Department of Epidemiology and Public Health, University of Maryland Greenebaum Comprehensive Cancer Center and University of Maryland School of Medicine, Baltimore, Maryland.
⁴ Department of Radiation Oncology, The Medical College of Wisconsin, Milwaukee, Wisconsin.
⁵ Biosciences Division, SRI International, Menlo Park, California.
⁶ Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom.
⁷ Fundación Pública Galega Medicina Xenómica, Instituto de Investigacion Sanitaria de Santiago de Compostela, Hospital Clínico Santiago de Compostela, Santiago de Compostela, A Coruña, Spain.
⁸ Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.
⁹ Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida.

No abstract available

Publication types